Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial - Summary - MDSpire

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

  • By

  • Joris Vangeneugden

  • Saar Vermijs

  • Peter De Kuyper

  • Camille Berquin

  • Nicolaas Lumen

  • Victor Declerck

  • Frederic Baekelandt

  • Christophe Ghysel

  • Yannic Raskin

  • Bernard Bynens

  • Kenzo Mestdagh

  • Pieter De Backer

  • Pieter De Visschere

  • Charlotte Debbaut

  • Charles Van Praet

  • Karel Decaestecker

  • July 17, 2026

Share

Objective:

To correct the conflict of interest statement regarding Author PDB's financial relationship with MEDANNOT s.r.o. in the context of the article on surgical approaches in robot-assisted partial nephrectomy.

Approach:
  • Correction: The conflict of interest statement was updated to reflect that Author PDB has been a co-founder and shareholder of MEDANNOT s.r.o. (Spania Dolina, Slovakia) since March 2024. MEDANNOT is an online platform for segmentation of CT scans into 3D models.
Key Findings:
  • The original conflict of interest statement was incorrect.
  • The updated statement clarifies the financial relationship of one author, which is essential for understanding potential biases.
Interpretation:

The correction ensures transparency regarding potential conflicts of interest among the authors.

Conclusion:

The article has been updated to accurately reflect the conflict of interest statement.

Sources:

Original Source(s)

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

  • by Joris Vangeneugden, Saar Vermijs, Peter De Kuyper, Camille Berquin, Nicolaas Lumen, Victor Declerck, Frederic Baekelandt, Christophe Ghysel, Yannic Raskin, Bernard Bynens, Kenzo Mestdagh, Pieter De Backer, Pieter De Visschere, Charlotte Debbaut, Charles Van Praet, Karel Decaestecker

  • July 17, 2026

Related Content

Efficacy and safety of antibody-drug conjugates in EGFR-mutant non-small cell lung cancer after tyrosine kinase inhibitor resistance: a systematic review and meta-analysis

Quantitative assessment of inter-observer consistency in target volume delineation following breast-conserving surgery and mastectomy

Non-metastatic pediatric head and neck rhabdomyosarcoma: a 24-year retrospective experience from Jordan